PRE icon

Prenetics Global

5.79 USD
-0.01
0.17%
At close Dec 26, 4:00 PM EST
1 day
-0.17%
5 days
1.94%
1 month
28.67%
3 months
38.19%
6 months
-5.24%
Year to date
3.02%
1 year
5.85%
5 years
-94.95%
10 years
-94.95%
 

About: Prenetics Global Ltd is a health sciences company dedicated to consumer and clinical health. Its consumer initiative is led by IM8, a new health and wellness brand, and Europa, a U.S. sports distribution company. The clinical division is led by Insighta, focused on multi-cancer early detection technologies. This is followed by ACT Genomics, which has achieved FDA clearance for genomic profiling of solid tumors, and CircleDNA, which uses NGS to offer DNA tests. Each Prenetics unit impacts health by 'enhancing life through science'.

Employees: 320

0
Funds holding %
of 6,812 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

14% more funds holding

Funds holding: 7 [Q2] → 8 (+1) [Q3]

0.75% less ownership

Funds ownership: 11.21% [Q2] → 10.45% (-0.75%) [Q3]

37% less capital invested

Capital invested by funds: $7.06M [Q2] → $4.47M (-$2.59M) [Q3]

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

Low target
$9
55%
upside
Avg. target
$9
55%
upside
High target
$9
55%
upside

1 analyst rating

positive
100%
neutral
0%
negative
0%
Cantor Fitzgerald
Ross Osborn
50% 1-year accuracy
24 / 48 met price target
55%upside
$9
Overweight
Reiterated
4 Dec 2024

Financial journalist opinion

Based on 3 articles about PRE published over the past 30 days

Neutral
GlobeNewsWire
3 weeks ago
Prenetics' IM8 and University of Oxford Begin Groundbreaking Space Experiment to Study Accelerated Aging and Longevity on the ISS with SpaceX, Supported by Space Applications Services
CHARLOTTE, N.C., Dec. 05, 2024 (GLOBE NEWSWIRE) -- Prenetics' IM8 is excited to announce that its groundbreaking month-long space experiment, in partnership with the University of Oxford and supported by Space Applications Services and Metavisionaries, is now underway aboard the International Space Station (ISS). Launched via SpaceX CRS-31 on November 4th at 9:29 pm EST, the mission aims to study accelerated aging and longevity by leveraging microgravity's unique environment to accelerate aging processes at the cellular level.
Prenetics' IM8 and University of Oxford Begin Groundbreaking Space Experiment to Study Accelerated Aging and Longevity on the ISS with SpaceX, Supported by Space Applications Services
Neutral
GlobeNewsWire
3 weeks ago
Prenetics Announces Participation in December Investor Conferences
CHARLOTTE, N.C., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Prenetics Global Limited, (NASDAQ: PRE) (“Prenetics” or the “Company”), a leading health sciences company, today announced that members of the Prenetics management team will participate in two upcoming investor conferences.
Prenetics Announces Participation in December Investor Conferences
Neutral
GlobeNewsWire
4 weeks ago
Prenetics Announces Third Quarter 2024 Financial Results
Revenue Grew 59.4% to $7.8 million from Prior Year and 30.9% Sequentially
Prenetics Announces Third Quarter 2024 Financial Results
Neutral
GlobeNewsWire
1 month ago
MULTIMEDIA UPDATE -- Nasdaq-Listed Prenetics and David Beckham Officially Launch IM8 Health
Beckham is a strategic investor in Prenetics and Co-Founding Partner for IM8 IM8 launch marks a bold entry into the $187 billion global consumer health market Launch follows recently announced Prenetics' acquisition of Europa, one of the largest sports nutrition distributors in the U.S. IM8 is now available at www.IM8health.com , shipping to 31 countries (David Beckham pictured with The Beckham Stack) CHARLOTTE, N.C., Nov. 18, 2024 (GLOBE NEWSWIRE) -- Prenetics, (NASDAQ: PRE) a leading health sciences company, in partnership with David Beckham, today announced the official launch of IM8.
MULTIMEDIA UPDATE -- Nasdaq-Listed Prenetics and David Beckham Officially Launch IM8 Health
Neutral
GlobeNewsWire
1 month ago
Nasdaq-Listed Prenetics and David Beckham Officially Launch IM8 Health
Beckham is a strategic investor in Prenetics and Co-Founding Partner for IM8 IM8 launch marks a bold entry into the $187 billion global consumer health market Launch follows recently announced Prenetics' acquisition of Europa, one of the largest sports nutrition distributors in the U.S. IM8 is now available at www.IM8health.com , shipping to 31 countries CHARLOTTE, N.C., Nov. 18, 2024 (GLOBE NEWSWIRE) -- Prenetics, (NASDAQ: PRE) a leading health sciences company, in partnership with David Beckham, today announced the official launch of IM8.
Nasdaq-Listed Prenetics and David Beckham Officially Launch IM8 Health
Neutral
GlobeNewsWire
1 month ago
Prenetics Announces Participation in the Sidoti Virtual Micro Cap Investor Conference
CHARLOTTE, N.C., Oct. 30, 2024 (GLOBE NEWSWIRE) -- Prenetics, (NASDAQ: PRE) a leading health sciences company, announced today that management will participate in the Sidoti Virtual Micro Cap Conference being held on November 13-14, 2024.
Prenetics Announces Participation in the Sidoti Virtual Micro Cap Investor Conference
Neutral
GlobeNewsWire
4 months ago
Prenetics Announces Acquisition of Europa Sports Partners in Strategic Expansion to Consumer Health and Wellness Industry
Europa Is One of the Largest Sports Nutrition Distributors With a Network of 10,000+ Gyms Across the United States Supports Prenetics' New Health and Wellness Brand IM8 with David Beckham as its Co-Founding Partner Projected Revenue of $100 Million+ in Consumer Segment for FY2025 CHARLOTTE, N.C., Aug. 19, 2024 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a leading health sciences company, is pleased to announce the acquisition of Europa Sports Partners (“Europa”) and subsidiary, Hubmatrix, a global ecommerce and retail logistics provider.
Prenetics Announces Acquisition of Europa Sports Partners in Strategic Expansion to Consumer Health and Wellness Industry
Neutral
GlobeNewsWire
5 months ago
Prenetics, NASDAQ Health Sciences Company, Partners with David Beckham
LOS ANGELES, July 11, 2024 (GLOBE NEWSWIRE) -- Prenetics, (NASDAQ: PRE) a leading health sciences company, is proud to announce that former international footballer, entrepreneur and philanthropist David Beckham has become a strategic investor in the business. Prenetics and Beckham will become co-founding partners of a new health and wellness brand, IM8, which will focus on cutting-edge consumer health products, with details to be announced at a later date.
Prenetics, NASDAQ Health Sciences Company, Partners with David Beckham
Neutral
GlobeNewsWire
5 months ago
Prenetics Welcomes Kathyrn M. Henry and David Vanderveen to Board of Directors
Adding Decades of Public Company and Board Expertise as Prenetics Readies for Expansion into Consumer Health and Wellness Adding Decades of Public Company and Board Expertise as Prenetics Readies for Expansion into Consumer Health and Wellness
Prenetics Welcomes Kathyrn M. Henry and David Vanderveen to Board of Directors
Neutral
GlobeNewsWire
6 months ago
Prenetics Announces First Quarter 2024 Financial Results
First Quarter Revenue Increased 30.2% and Gross Profit Increased 159.8% from Prior Year Quarter
Prenetics Announces First Quarter 2024 Financial Results
Charts implemented using Lightweight Charts™